226 related articles for article (PubMed ID: 16267260)
1. Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient mice.
Phan O; Ivanovski O; Nguyen-Khoa T; Mothu N; Angulo J; Westenfeld R; Ketteler M; Meert N; Maizel J; Nikolov IG; Vanholder R; Lacour B; Drüeke TB; Massy ZA
Circulation; 2005 Nov; 112(18):2875-82. PubMed ID: 16267260
[TBL] [Abstract][Full Text] [Related]
2. Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice.
Massy ZA; Ivanovski O; Nguyen-Khoa T; Angulo J; Szumilak D; Mothu N; Phan O; Daudon M; Lacour B; Drüeke TB; Muntzel MS
J Am Soc Nephrol; 2005 Jan; 16(1):109-16. PubMed ID: 15563564
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular effects of uremia in apolipoprotein E-deficient mice.
Bro S
Dan Med Bull; 2009 Nov; 56(4):177-92. PubMed ID: 19939336
[TBL] [Abstract][Full Text] [Related]
4. Effect of simvastatin in apolipoprotein E deficient mice with surgically induced chronic renal failure.
Ivanovski O; Szumilak D; Nguyen-Khoa T; Nikolov IG; Joki N; Mothu N; Maizel J; Westenfeld R; Ketteler M; Lacour B; Drüeke TB; Massy ZA
J Urol; 2008 Apr; 179(4):1631-6. PubMed ID: 18295249
[TBL] [Abstract][Full Text] [Related]
5. Lanthanum carbonate, like sevelamer-HCl, retards the progression of vascular calcification and atherosclerosis in uremic apolipoprotein E-deficient mice.
Nikolov IG; Joki N; Nguyen-Khoa T; Guerrera IC; Maizel J; Benchitrit J; Machado dos Reis L; Edelman A; Lacour B; Jorgetti V; Drüeke TB; Massy ZA
Nephrol Dial Transplant; 2012 Feb; 27(2):505-13. PubMed ID: 21705467
[TBL] [Abstract][Full Text] [Related]
6. Blockage of the renin-angiotensin system attenuates mortality but not vascular calcification in uremic rats: sevelamer carbonate prevents vascular calcification.
Tokumoto M; Mizobuchi M; Finch JL; Nakamura H; Martin DR; Slatopolsky E
Am J Nephrol; 2009; 29(6):582-91. PubMed ID: 19145073
[TBL] [Abstract][Full Text] [Related]
7. The antioxidant N-acetylcysteine prevents accelerated atherosclerosis in uremic apolipoprotein E knockout mice.
Ivanovski O; Szumilak D; Nguyen-Khoa T; Ruellan N; Phan O; Lacour B; Descamps-Latscha B; Drüeke TB; Massy ZA
Kidney Int; 2005 Jun; 67(6):2288-94. PubMed ID: 15882270
[TBL] [Abstract][Full Text] [Related]
8. Repopulation of apolipoprotein E knockout mice with CCR2-deficient bone marrow progenitor cells does not inhibit ongoing atherosclerotic lesion development.
Guo J; de Waard V; Van Eck M; Hildebrand RB; van Wanrooij EJ; Kuiper J; Maeda N; Benson GM; Groot PH; Van Berkel TJ
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1014-9. PubMed ID: 15774908
[TBL] [Abstract][Full Text] [Related]
9. Uremia-specific effects in the arterial media during development of uremic atherosclerosis in apolipoprotein E-deficient mice.
Bro S; Borup R; Andersen CB; Moeller F; Olgaard K; Nielsen LB
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):570-5. PubMed ID: 16373611
[TBL] [Abstract][Full Text] [Related]
10. Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice.
Custodis F; Baumhäkel M; Schlimmer N; List F; Gensch C; Böhm M; Laufs U
Circulation; 2008 May; 117(18):2377-87. PubMed ID: 18443241
[TBL] [Abstract][Full Text] [Related]
11. Glucose-6-phosphate dehydrogenase deficiency decreases vascular superoxide and atherosclerotic lesions in apolipoprotein E(-/-) mice.
Matsui R; Xu S; Maitland KA; Mastroianni R; Leopold JA; Handy DE; Loscalzo J; Cohen RA
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):910-6. PubMed ID: 16439706
[TBL] [Abstract][Full Text] [Related]
12. Effect of oral calcium carbonate on aortic calcification in apolipoprotein E-deficient (apoE-/-) mice with chronic renal failure.
Phan O; Ivanovski O; Nikolov IG; Joki N; Maizel J; Louvet L; Chasseraud M; Nguyen-Khoa T; Lacour B; Drüeke TB; Massy ZA
Nephrol Dial Transplant; 2008 Jan; 23(1):82-90. PubMed ID: 17977878
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of klotho gene in uremic atherosclerosis in apolipoprotein E-deficient mice.
Yu J; Deng M; Zhao J; Huang L
Biochem Biophys Res Commun; 2010 Jan; 391(1):261-6. PubMed ID: 19912987
[TBL] [Abstract][Full Text] [Related]
14. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
[TBL] [Abstract][Full Text] [Related]
15. Development of atherosclerosis in Balb/c apolipoprotein E-deficient mice.
Desai A; Zhao Y; Warren JS
Cardiovasc Pathol; 2008; 17(4):233-40. PubMed ID: 18402814
[TBL] [Abstract][Full Text] [Related]
16. Long-term administration of 3-deazaadenosine does not alter progression of advanced atherosclerotic lesions in apolipoprotein E-deficient mice.
Preusch MR; Bea F; Yang SH; Kreuzer J; Isermann B; Pedal I; Rosenfeld ME; Katus HA; Blessing E
J Cardiovasc Pharmacol; 2007 Aug; 50(2):206-12. PubMed ID: 17703138
[TBL] [Abstract][Full Text] [Related]
17. Intrauterine exposure to maternal atherosclerotic risk factors increases the susceptibility to atherosclerosis in adult life.
Alkemade FE; Gittenberger-de Groot AC; Schiel AE; VanMunsteren JC; Hogers B; van Vliet LS; Poelmann RE; Havekes LM; Willems van Dijk K; DeRuiter MC
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2228-35. PubMed ID: 17656671
[TBL] [Abstract][Full Text] [Related]
18. Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions.
Yoshii T; Iwai M; Li Z; Chen R; Ide A; Fukunaga S; Oshita A; Mogi M; Higaki J; Horiuchi M
Hypertens Res; 2006 Jun; 29(6):457-66. PubMed ID: 16940709
[TBL] [Abstract][Full Text] [Related]
19. Oral administration of tetrahydrobiopterin slows the progression of atherosclerosis in apolipoprotein E-knockout mice.
Hattori Y; Hattori S; Wang X; Satoh H; Nakanishi N; Kasai K
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):865-70. PubMed ID: 17272747
[TBL] [Abstract][Full Text] [Related]
20. Peritoneal delivery of sodium pyrophosphate blocks the progression of pre-existing vascular calcification in uremic apolipoprotein-E knockout mice.
de Oliveira RB; Louvet L; Riser BL; Barreto FC; Benchitrit J; Rezg R; Poirot S; Jorgetti V; Drüeke TB; Massy ZA
Calcif Tissue Int; 2015 Aug; 97(2):179-92. PubMed ID: 26087714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
